BAART Programs and MedMark Treatment Centers of California Now Accepting Anthem Blue Cross for Opioid Addiction Treatment
Two outpatient, opioid addiction treatment programs in California, have announced that they are now in network with Anthem Blue Cross of California.
LEWISVILLE, TX – BAART Programs and MedMark Treatment Centers, two BayMark Health Services brands in California, have announced that they are now in network with Anthem Blue Cross of California. BAART Programs and MedMark Treatment Centers provide safe, effective medication-assisted treatment (MAT) with methadone and buprenorphine supported by counseling for those struggling with opioid use disorder.
“Californians have been significantly impacted by the opioid crisis, experiencing over 2,000 opioid overdose deaths in 2017.” shared David K. White, Ph.D., CEO of BayMark Health Services. “One of our primary goals as a treatment provider is to improve accessibility and affordability of effective options for individuals struggling with the disease of opioid addiction. By working with insurers, we have the opportunity to further that goal, and open up our comprehensive services to hundreds of thousands of Anthem Blue Cross subscribers across the state.”
BAART and MedMark Opioid Treatment Programs (OTPs) are known across California as providers of quality, evidence-based medication-assisted treatment services. In addition to medication, wrap-around services which include counseling, addiction education, relapse prevention, lab testing, coordinated care for pregnancy and linkages to community resources are available to assist patients on their path to recovery.
The mission is to provide comprehensive medication-assisted treatment for opioid use disorder and other health care services to foster wellness, longevity and socially responsible behavior for the patients we serve.
To find an Opioid Treatment Program near you visit: https://baymark.com/treatment-locations/
About BayMark Health Services:
BayMark Health Services provides medication-assisted treatment to more than 49,000 patients in recovery from substance use disorder across the United States and Ontario, Canada. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances. The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.